News

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

In case you missed it, this week we had news on phase 3 data for zasocitinib in psoriasis, wildfire air pollution's impact on AD clinic visits, the FDA's clearance of REX-8756's IND application, and more.

In part 3 of this supplement, experts discuss treatment options for adults with hormonal pattern acne and PIH.

Discover effective treatment strategies for keloids and hypertrophic scars in skin of color, emphasizing personalized approaches and combination therapies.

Energy and protein drinks may exacerbate acne through high sugar and insulin levels, impacting skin health among athletes and students.

Discover the latest trends in aesthetic dermatology for 2025, including innovative treatments and the impact of social media on patient choices.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of December.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed the 3 latest non-steroidal topicals for atopic dermatitis at the Horizons in Advanced Practice meeting.

Experts discuss real-world strategies for managing alopecia areata, emphasizing JAK inhibitors, psychosocial impacts, and personalized patient care approaches.

What were the top dermatology hits of 2025?

In part 3 of this Case-Based Roundtable supplement, experts discuss psoriatic therapies for hair-baring areas.

Omar Noor, MD, recently presented 3 cases of psoriasis in older patients at Horizons in Advanced Practice to discuss available treatment options and considerations for Medicare and in-office injections.

A study reveals stress coping strategies and eosinophil levels impact CU in adolescents, highlighting the need for integrated psychological support.

Explore the risks of bypassing dermatologists for DIY skin care and telehealth treatments, highlighting real patient experiences and expert insights.

Zasocitinib emerges as a promising oral therapy for psoriasis, achieving significant skin clearance and favorable safety in recent phase 3 trials.

At a recent Case-Based Roundtable® event, Aaron Farberg, MD, moderated a discussion of challenging atopic dermatitis cases spanning adult, adolescent, and pediatric patients.

In part 2 of this supplement, experts discuss therapies for inflammatory acne

Porter leads a dynamic roundtable on hidradenitis suppurativa, exploring innovative treatments and collaborative strategies for improved patient outcomes.

Early-phase development introduces a potential first-in-class oral approach targeting type 2 inflammation relevant to dermatologic diseases.

Soligenix reveals promising results from its phase 2a study of SGX302, a novel therapy for mild-to-moderate psoriasis, enhancing patient experience and efficacy.

New research reveals that combining DecisionDx-UM and PRAME significantly enhances survival predictions for uveal melanoma.

Discover the latest breakthroughs in atopic dermatitis and psoriasis treatments for 2025, enhancing patient care and individualizing therapy options.

This review of the latest dermatologic studies includes case studies on allergic contact dermatitis from UV nail polish, the introduction of the visual aesthetics methodology, a review of topical timolol, and more.

An expert panel endorses Castle Biosciences’ 31-GEP test, enhancing melanoma management through personalized risk assessment and improved prognostic accuracy.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, discussed psoriasis in high-impact sites, overall psoriatic disease, and available therapies.

Wildfire air pollution significantly increases atopic dermatitis and itch-related dermatologic visits, highlighting the urgent need for skin protection during poor air quality.

In part 2 of this Case-Based Roundtable supplement, experts discuss therapeutic options for psoriasis when considering involvement of special areas.

In part 1 of this supplement, experts discuss current and emerging treatments for patients, considering lifestyle choices.

A bentonite and Alcea sulphurea facial mask significantly improved acne severity and patient satisfaction in a recent clinical trial.